Is Plexus (PLXS) Undervalued After Its Pullback Or Already Fully Valued?

Plexus (PLXS) is back in focus after fresh performance data highlighted how a hypothetical US$1,000 investment five years ago would now be worth US$2,460.88. This has sharpened investor interest in the stock’s compounding profile.

Plexus shares now trade at US$234.94, and after a 1 day share price gain of 1.94% that follows a 7 day drop of 8.87% and a 90 day decline of 9.39%, short term momentum looks softer. This comes even though the year to date share price return of 54.33% sits alongside a 5 year total shareholder return of 147.10%, which reflects the longer term compounding story.

Capitalize on Plexus highlighting the power of compounding by scanning a curated 35 high quality undervalued stocks that may offer similar long term potential at different stages of their journey.

Plexus has delivered strong compounding for patient holders, yet the recent pullback raises a different issue. Does that track record come at a fair price today, or has the stock already charged ahead of itself?

Most Popular Narrative: 23% Undervalued

The most followed valuation story on Plexus pegs fair value at $304.60, comfortably above the last close of $234.94. This puts the current pullback in a very different light for long term holders watching that gap.

Continued investment and performance in high-value engineering and design services, alongside a record US$4.5b qualified manufacturing funnel that includes growing exposure to data center power, robotics, industrial automation and energy storage, is intended to move Plexus further up the value chain. This can support larger program sizes, higher gross margins and stronger earnings resilience.

See why 1 investors see Plexus as 23% undervalued.

Result: Fair Value of $304.60 (UNDERVALUED)

Still, the Plexus narrative can be knocked off course if insider selling continues to pressure sentiment, or if that US$4.5b funnel proves slower to convert than hoped.

Find out about the key risks to this Plexus narrative.

Another Angle On Plexus Valuation

The story so far leans on a fair value of $304.60, which paints Plexus as undervalued. A simple P/E cross-check tells a tougher story. The stock trades on 33.8x earnings versus a 28.7x industry average and a 28.5x fair ratio, which pushes the multiple into richer territory and raises the question of how much execution room is left if growth slips.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Plenty in this Plexus story points to past rewards and rich expectations. The real question is what you think happens next. Move quickly, review the numbers in detail, compare them with peers, and then weigh those 1 or more potential upsides highlighted in the 4 key rewards.

Looking for more Plexus style ideas?

If Plexus has you thinking about what is possible over a few patient years, broaden your opportunity set using the Simply Wall Street Screener today.

• Target potential mispricings by scanning a curated pool of companies flagged as 35 high quality undervalued stocks that could offer a more attractive entry point than their current sentiment suggests.
• Prioritize resilience over drama and filter for businesses with stronger finances using the list of solid balance sheet and fundamentals (25 results) before the crowd catches on.
• Hunt for under-the-radar potential by reviewing the 20 high quality undiscovered gems that might not be front page yet but still show robust underlying fundamentals.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com